Chimeric antigen receptor T-cell therapy in patients with malignant glioma-From neuroimmunology to clinical trial design considerations.
Saved in:
| Title: | Chimeric antigen receptor T-cell therapy in patients with malignant glioma-From neuroimmunology to clinical trial design considerations. |
|---|---|
| Authors: | Gallus M; Department of Neurological Surgery, Unversity of California San Fracisco, San Francisco, California, USA., Young JS; Department of Neurological Surgery, Unversity of California San Fracisco, San Francisco, California, USA., Cook Quackenbush S; The Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA., Khasraw M; The Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA., de Groot J; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Neurological Surgery, Unversity of California San Fracisco, San Francisco, California, USA., Okada H; The Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Neurological Surgery, Unversity of California San Fracisco, San Francisco, California, USA. |
| Source: | Neuro-oncology [Neuro Oncol] 2025 Feb 10; Vol. 27 (2), pp. 352-368. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-5866 |
|---|---|
| DOI: | 10.1093/neuonc/noae203 |
